Regulatory Post-Marketing Surveillance Study for TETRAXIM™

Clinical trial NCT01437423 · COMPLETED

Trial details

NCT number: NCT01437423
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diphtheria Tetanus Pertussis Poliomyelitis

Start date: 2011-06-01
Primary completion: 2015-11-01
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.